Uveal Melanoma in Asians: A Review.
Asian
Choroid
Eye
Iris
Melanoma
Tumor
Uvea
Journal
Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
01
05
2020
accepted:
02
11
2020
entrez:
26
7
2021
pubmed:
27
7
2021
medline:
27
7
2021
Statut:
ppublish
Résumé
Despite limited data, some differences in the clinical profile can be observed in Asian population when compared with presentation of uveal melanoma (UM) in white population. The incidence of UM is higher in Whites than in Asians. For the purpose of comparison with Asian population, data from North America, Europe, and Australia were considered as that of "white" population. The annual incidence of UM has been reported to be 5-6 cases/million in whites. The incidence in different parts of Asia is estimated at 0.2-0.6 per million. The age of presentation is around 40-55 years in Asians, which is younger when compared to that of whites (mean age of 58 years). At presentation, mean basal diameter of tumors in Asians is greater compared to whites but overall, medium-size tumors are most common. Clinical presentation is straightforward in majority of cases with retinal detachment, acute glaucoma, uveitis, cataract, or vitreous hemorrhage as common symptoms. Epithelioid cell-type variant carries the worst prognosis. Management options for choroidal melanoma include transpupillary thermotherapy, plaque radiotherapy, charged particle irradiation, local resection, enucleation, or orbital exenteration. Most commonly used modalities are enucleation and plaque radiotherapy.
Identifiants
pubmed: 34307326
doi: 10.1159/000512738
pii: oop-0007-0159
pmc: PMC8280446
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
159-167Informations de copyright
Copyright © 2021 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest to disclose. Prof. Singh (as one co-author) is the Editor-in-Chief of the journal Ocular Oncology and Pathology.
Références
Ophthalmology. 2008 Apr;115(4):757; author reply 757-9
pubmed: 18387420
Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):652-6
pubmed: 23197684
Melanoma Res. 2017 Oct;27(5):492-497
pubmed: 28609317
Ophthalmology. 2017 May;124(5):609-618
pubmed: 28159380
J Curr Ophthalmol. 2018 Mar 22;30(2):102-109
pubmed: 29988936
Indian J Ophthalmol. 2016 Jun;64(6):415-21
pubmed: 27488148
Mol Vis. 2009 Oct 22;15:2146-54
pubmed: 19898689
Turk Patoloji Derg. 2016;32(3):186-92
pubmed: 27562393
PLoS One. 2015 Dec 08;10(12):e0144562
pubmed: 26645696
J Neurosurg. 2010 Dec;113 Suppl:34-8
pubmed: 21121785
Arch Ophthalmol. 1992 Feb;110(2):245-50
pubmed: 1531290
Nepal J Ophthalmol. 2019 Jan;11(21):64-73
pubmed: 31523069
Curr Eye Res. 2017 May;42(5):759-765
pubmed: 27911584
Br J Ophthalmol. 2002 Mar;86(3):333-8
pubmed: 11864894
Eye (Lond). 2015 Aug;29(8):1027-35
pubmed: 26248525
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4719-24
pubmed: 26207308
Am J Ophthalmol. 1983 Oct;96(4):502-9
pubmed: 6624832
Indian J Ophthalmol. 2004 Mar;52(1):41-4
pubmed: 15132378
Eye (Lond). 2004 Feb;18(2):152-8
pubmed: 14762407
J AAPOS. 2012 Feb;16(1):10-6
pubmed: 22370659
Int Ophthalmol. 2014 Apr;34(2):235-9
pubmed: 23824661
Control Clin Trials. 1993 Oct;14(5):362-91
pubmed: 8222668
South Asian J Cancer. 2017 Jul-Sep;6(3):134-136
pubmed: 28975125
Isr Med Assoc J. 2009 May;11(5):280-5
pubmed: 19637505
Oman J Ophthalmol. 2018 May-Aug;11(2):175-177
pubmed: 29930457
Singapore Med J. 2019 Sep;60(9):474-478
pubmed: 31197380
Eye (Lond). 2012 Feb;26(2):292-9
pubmed: 22079972
Am J Ophthalmol. 2005 Oct;140(4):612-7
pubmed: 16226513
Oman J Ophthalmol. 2011 Jan;4(1):28-31
pubmed: 21713238
Saudi J Ophthalmol. 2009 Jul;23(2):157-63
pubmed: 23960853
Clin Cancer Res. 2003 Sep 15;9(11):4159-64
pubmed: 14519640
Eye (Lond). 1998;12 ( Pt 5):781-2
pubmed: 10070508
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):270-6
pubmed: 23414768
Ophthalmology. 2017 Oct;124(10):1523-1531
pubmed: 28495150
Ophthalmology. 2013 Sep;120(9):1946-7.e2
pubmed: 24001534
Curr Eye Res. 2004 Jun;28(6):409-16
pubmed: 15512948
J Clin Oncol. 2005 Nov 1;23(31):8076-80
pubmed: 16258106
Ophthalmic Genet. 2019 Aug;40(4):338-341
pubmed: 31407624
Oman J Ophthalmol. 2016 Sep-Dec;9(3):187-188
pubmed: 27843240
Acta Ophthalmol. 2013 Nov;91(7):e583-4
pubmed: 24131706
Ophthalmology. 2011 Sep;118(9):1881-5
pubmed: 21704381
Cancer Res Treat. 2018 Apr;50(2):335-344
pubmed: 28421723
Br J Ophthalmol. 2014 Jan;98(1):82-5
pubmed: 24169650